# Alprazolam as Conscious Sedation for Upper Gastrointestinal Endoscopy

> **NCT01949038** · PHASE2,PHASE3 · COMPLETED · sponsor: **Isfahan University of Medical Sciences** · enrollment: 220 (actual)

## Conditions studied

- Diagnostic Esophagogastroduodenoscopy

## Interventions

- **DRUG:** Oral alprazolam
- **DRUG:** Sublingual alprazolam
- **DRUG:** Oral placebo
- **DRUG:** Sublingual placebo

## Key facts

- **NCT ID:** NCT01949038
- **Lead sponsor:** Isfahan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-10
- **Final completion:** 2013-01
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2013-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01949038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01949038, "Alprazolam as Conscious Sedation for Upper Gastrointestinal Endoscopy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01949038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*